Search Results - Harker-Murray, Amy
- Showing 1 - 3 results of 3
-
1
-
2
DC-HIL(+) CD14(+) HLA-DR(no/low) Cells Are a Potential Blood Marker and Therapeutic Target for Melanoma by Turrentine, Jake, Chung, Jin-Sung, Nezafati, Kaveh, Tamura, Kyoichi, Harker-Murray, Amy, Huth, James, Sharma, Rohit R., Harker, David B., Ariizumi, Kiyoshi, Cruz, Ponciano D.
Published 2014Text -
3
Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF mutated melanoma: a randomized phase 2 trial by Algazi, Alain P., Othus, Megan, Daud, Adil I., Lo, Roger S., Mehnert, Janice M., Truong, Thach-Giao, Conry, Robert, Kendra, Kari, Doolittle, Gary C., Clark, Joseph I., Messino, Michael J., Moore, Dennis F., Lao, Christopher, Faller, Bryan A., Govindarajan, Rangaswamy, Harker-Murray, Amy, Dreisbach, Luke, Moon, James, Grossmann, Kenneth F., Ribas, Antoni
Published 2020Text